Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

I01CX000345-06
Title: Clinically Actionable Neoantigens in Non-Small Cell Lung Cancer
Principal Investigator:

Steven M. Dubinett

Location: West Los Angeles, CA
Congressional District Code: 33
Research Service: Clinical Science R&D
Project Period: October 2017 - September 2021
FY 2021 Funding Amount: $300,000
Total Award Amount
(all years):
$1,320,228
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER


Excerpt:

Clinically actionable neoantigens in non-small cell lung cancer Lung cancer is the leading cause of cancer death among US Veterans as well as the world's leading cause of cancer death. Environmental exposure and tobacco use among Veterans operate together to increase risk. Unleashing the immune response against pulmonary premalignancy could transform therapy and outcomes. Here, we propose to lay the ground work for lung “cancer interception,” a strategy that seeks to block the progression of pre...



Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.